Global tests of haemostasis;Hämostaseologische globalteste

Hamostaseologie

Volumn 26, Issue 1, 2006, Pages 27-37

  Spannagl, Michael ^a   Moessmer, G ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Global tests of haemostasis; Plasma; Preanalytical aspects; Predictive value; Whole blood

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; HEPARIN; HIRUDIN; LUPUS ANTICOAGULANT; PROTHROMBIN; REAGENT; CITRIC ACID;

ANALYTIC METHOD; ANALYTICAL RESEARCH; BLOOD CLOTTING; DRUG EFFECT; HEMOSTASIS; INTERNATIONAL NORMALIZED RATIO; LABORATORY; MEDICAL INSTRUMENTATION; PROTHROMBIN TIME; REVIEW; BLOOD; HUMAN;

BLOOD COAGULATION; CITRATES; HEMOSTASIS; HEMOSTATIC TECHNIQUES; HUMANS; INTERNATIONAL NORMALIZED RATIO; PROTHROMBIN TIME;

EID: 33645226152     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616873     Document Type: Review

References (27)

1. Adcock DM, Kressin DC, Marlar RA. Effects of 3.2% vs. 3.8% citrate concentration on routine coagulation testing. Am J Clin Pathol 1997; 107: 105-10.
2. Calatzis A, Heesen M, Spannagl M. Point-of-care testing of hemostatic alterations in anaesthesia and intensive care. Anaesthesist 2003; 52: 229-37.
3. Cammerer U, Dietrich W, Kampf T et al. The predictive value of modified computerized thromboeblastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003; 96: 51-7.
4. Chantarangkul V, Tripodi A, Clerici M et al. Assessment of the influence of citrate concentration on the international normalized ratio (INR) determined with twelve reagent-instrument combinations. Thromb Haemost 1998; 80: 258-62.
5. Chee YL, Greaves M. Role of coagulation testing in predicting bleeding risk. Hematol J 2003; 4: 373-8.
6. Davis CL, Chandler WL. Thromboelastography for the prediction of bleeding after transplant renal biopsy. J Am Soc Nephrol 1995; 6: 1250-5.
7. Duncan EM, Casey CR, Duncan BM et al. Effect of concentration of trisodium citrate anticoagulant on calculation of the international normalised ratio and the international sensitivity index of thromboplastin. Thromb Haemost 1994; 72: 84-8.
8. Fries D, Innerhofer P, Klingler A et al. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg 2002; 94: 1280-7.
9. Hartert H. Blutgerinnungstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Kli. Wochenschrift 1948; 26: 577-83.
10. Horstkotte D, Piper C. Improvement of oral anticoagulation by INR self management. J Heart Valve Disease 2004; 13: 335-8.
11. Ingram GIC, Hills M. The prothrombin time test: Effect of varying citrate concentration. Thromb Haemost 1976; 36: 230-6.
12. Ingram GIC, Hills M (for the International Committee for Standardization in Haematology). Reference method for the one-stage prothrombin time test on human blood. Thromb Haemost 1976; 36: 237-8.
13. Kaufmann CR, Dwyer KM, Crews JD et al. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997; 42: 716-20.
14. Koepke JA, Rogers J, Allwier MJ. Pre-instrumental variables in coagulation testing. Am J Clin Pathol 1975; 61: 591-6.
15. Moessmer G. Präanalytik von haemostaseologischen Laboruntersuchungen. Bayer Internist 2004; 24: 124-32.
16. nd ed. NCCLS document 1991; H21-A2. Villanova, PA, USA.
17. Orlikowski CE, Payne AJ, Moodley J et al. Thrombelastography after aspirin ingestion in pregnant and non-pregnant subjects. Br J Anaesth 1992; 69: 159-61.
18. Peterson P, Gottfried EL. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT). Thromb Haemost 1982; 47: 101-3.
19. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinol 2001; 12: 327-37.
20. Spinler SA, Wittkowsky AK, Nutescu EA et al. Anticoagulation monotoring part 29. Unfractionated heparin and molecular-weight heparin. Ann Pharmacother 2005; 39: 1275-85.
21. Töpfer G, Funke U, Schulze M et al. Präanalytische Probleme bei Gerinnungsuntersuchungen im venösen Citratblut, Katheterblut und Kapillarblut. J Lab Med 2000; 24: 514-20.
22. Töpfer G, Lutze G, Sauer K et al. Einfluß der Citratkonzentration im Blutentnahmeröhrchen auf hämostaseologische Meßgrößen. J Lab Med 2001; 25: 162-8.
23. Van den Besselaar AMH, Meeuwisse-Braun J, Jansen-Gruter R et al. onitoring heparin therapy by the activated partial thromboplastin time. The effect of preanalytical conditions. Thromb Haemost 1987; 58: 226-31.
24. Van den Besselaar AMHP, Chantarangkul V, Tripodi A. A comparison of two sodium citrate concentrations in two evacuated blood collection systems for prothrombin time and ISI determination. Thromb Haemost 2000; 84: 664-7.
25. Vorweg M, Hartmann B, Knuttgen D et al. Management of fulminant fibrinolysis during abdominal aortic surgery. J Cardiothorac Vasc Anesth 2001; 15: 764-7.
26. WHO Expert Committee on Biological Standardization. Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. WHO Technical Report 1999; 889; Geneva, Switzerland.
27. Witt I, Beeser H, Müller-Berghaus G. Minimalanforderungen zur Gewinnung von Citratplasma für haemostaseologische Analysen. Laboratoriumsmedizin, 1995; 19: 245-7.